Microwell-based pancreas-on-chip model enhances genes expression and functionality of rat islets of Langerhans.

Molecular and Cellular Endocrinology
Amal EssaouibaEric Leclerc

Abstract

Organ-on-chip technology is a promising tool for investigating physiological in vitro responses in drug screening development, and in advanced disease models. Within this framework, we investigated the behavior of rat islets of Langerhans in an organ-on-chip model. The islets were trapped by sedimentation in a biochip with a microstructure based on microwells, and perfused for 5 days of culture. The live/dead assay confirmed the high viability of the islets in the biochip cultures. The microfluidic culture leads to upregulation of mRNA levels of important pancreatic islet genes: Ins1, App, Insr, Gcgr, Reg3a and Neurod. Furthermore, insulin and glucagon secretion were higher in the biochips compared to the Petri conditions after 5 days of culture. We also confirmed glucose-induced insulin secretion in biochips via high and low glucose stimulations leading to high/low insulin secretion. The high responsiveness of the pancreatic islets to glucagon-like peptide 1 (GLP-1) stimulation in the biochips was reflected by the upregulation of mRNA levels of Gcgr, Reg3a, Neurog3, Ins1, Ins2, Stt and Glp-1r and by increased insulin secretion. The results obtained highlighted the functionality of the islets in the biochips and illustrated the...Continue Reading

References

Mar 30, 2002·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Wolfgang MoritzMarkus Weber
Jul 31, 2003·Current Opinion in Genetics & Development·Maya Kumar, Doug Melton
Dec 23, 2003·The Journal of Biological Chemistry·Lan WuAlvin C Powers
Sep 14, 2006·Transplantation·Yukihide YonekawaShinichi Matsumoto
Jan 18, 2007·Proceedings of the National Academy of Sciences of the United States of America·Wei-Heong Tan, Shoji Takeuchi
Feb 12, 2009·Lab on a Chip·Javeed Shaikh MohammedDavid T Eddington
Feb 25, 2010·Chemical Society Reviews·Edmond W K Young, David J Beebe
Apr 9, 2010·Cell Metabolism·Chunyan GuJacqueline E Lee
Apr 2, 2011·The Journal of Biological Chemistry·Shi-Ying DingMegan A Rizzo
Nov 19, 2011·Drug Discovery Today·Amir M GhaemmaghamiAli Khademhosseini
May 5, 2012·Lab on a Chip·Dongeun HuhDonald E Ingber
Aug 6, 2014·Nature Biotechnology·Sangeeta N Bhatia, Donald E Ingber
Aug 12, 2014·Biosensors & Bioelectronics·Skarphedinn HalldorssonRonan M T Fleming
Jan 9, 2015·The Journal of Endocrinology·Maureen J Charron, Patricia M Vuguin
Oct 4, 2015·Biochemical Pharmacology·Aileen King, James Bowe
Apr 29, 2016·Upsala Journal of Medical Sciences·Leif JanssonPer-Ola Carlsson
Nov 1, 2016·Nature Reviews. Nephrology·Ferruh ArtuncHans-Ulrich Häring
Mar 30, 2017·Experimental Cell Research·Nathalie Jouvet, Jennifer L Estall
Dec 29, 2017·Advanced Healthcare Materials·Sang Hun LeeLuke P Lee
Jun 7, 2018·BMC Public Health·José Adailton da SilvaEva Emanuela Lopes Cavalcante Feitosa
Oct 26, 2018·Advanced Drug Delivery Reviews·Julia RogalPeter Loskill
Jun 27, 2019·Journal of Diabetes Research·Celestino SarduGaetano Santulli
Jun 27, 2019·Matrix Biology : Journal of the International Society for Matrix Biology·Aline ZbindenPeter Loskill
Dec 7, 2019·Science Advances·Yesl JunSang-Hoon Lee

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Biology of GLP-1

Glucagon-like peptide 1 (GLP-1) plays a role in glucose metabolism, energy homeostasis, and inflammation suppression. GLP-1 receptor signaling has been shown to impact cardiovascular function. This feed focuses on the role of GLP-1 and GLP-1 receptor agonists on cardiovascular biology.

Related Papers

Archives internationales de physiologie et de biochimie
W MalaisseM Mahy
Nature Biotechnology
A Persidis
Nature Biotechnology
© 2022 Meta ULC. All rights reserved